Form 4 for IDXX Idexx Laboratories
Accepted 2026-08-24 17:00:10 ET · period of report 2026-08-20 · accession 0000874716-26-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-24 17:00 | 2026-08-20 | IDXX | Emerson Andrew | EVP, CFO, Treas | M - OptEx | $178.26 | +265 | 4,507 | +6% | +$47.2K |
| D | 2026-08-24 17:00 | 2026-08-20 | IDXX | Emerson Andrew | EVP, CFO, Treas | F - Tax | $0.00 | -86 | 4,421 | -2% | $0 |
| D | 2026-08-24 17:00 | 2026-08-20 | IDXX | Emerson Andrew | EVP, CFO, Treas | M - OptEx | — | -265 | 925 | -22% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-20 | M | A | 265 | $178.26 | 4,507.44 | D | — | — | (F1) Includes a total of 20 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2026 and June 30, 2026. |
| 2 | Common | Common Stock | 2026-08-20 | F | D | 86 | $0.00 | 4,421.44 | D | — | — | |
| 3 | Derivative | Incentive Stock Option (right-to-buy) | 2026-08-20 | M | D | 265 | — | 925 | D | $178.26 · — to 2028-02-13 | 265 Common Stock | (F3) Not applicable (F2) Grant of option to buy 1,190 shares of Issuer common stock that became exercisable in one installment on February 14, 2023. |